del(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemia.
about
The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
P2860
del(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
del(15q) is a recurrent minor- ...... chronic myelogenous leukemia.
@ast
del(15q) is a recurrent minor- ...... chronic myelogenous leukemia.
@en
type
label
del(15q) is a recurrent minor- ...... chronic myelogenous leukemia.
@ast
del(15q) is a recurrent minor- ...... chronic myelogenous leukemia.
@en
prefLabel
del(15q) is a recurrent minor- ...... chronic myelogenous leukemia.
@ast
del(15q) is a recurrent minor- ...... chronic myelogenous leukemia.
@en
P2093
P2860
P1476
del(15q) is a recurrent minor- ...... chronic myelogenous leukemia.
@en
P2093
C Cameron Yin
Effrosyni Apostolidou
L Jeffrey Medeiros
Lynne V Abruzzo
Xiaoyan Qiu
P2860
P356
10.1016/J.CANCERGENCYTO.2009.02.017
P577
2009-07-01T00:00:00Z